.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Citi
UBS
Cipla
Cerilliant
Express Scripts
Covington
Johnson and Johnson
Chinese Patent Office
Teva

Generated: July 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203388

« Back to Dashboard
NDA 203388 describes ERIVEDGE, which is a drug marketed by Genentech and is included in one NDA. It is available from one supplier. There are two patents protecting this drug. Additional details are available on the ERIVEDGE profile page.

The generic ingredient in ERIVEDGE is vismodegib. One supplier is listed for this compound. Additional details are available on the vismodegib profile page.

Summary for NDA: 203388

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 203388

Suppliers and Packaging for NDA: 203388

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ERIVEDGE
vismodegib
CAPSULE;ORAL 203388 NDA Genentech, Inc. 50242-140 50242-140-01 1 BOTTLE, PLASTIC in 1 CARTON (50242-140-01) > 28 CAPSULE in 1 BOTTLE, PLASTIC

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength150MG
Approval Date:Jan 30, 2012TE:RLD:Yes
Patent:► SubscribePatent Expiration:Nov 11, 2028Product Flag?YSubstance Flag?YDelist Request?
Patent:► SubscribePatent Expiration:Dec 15, 2028Product Flag?Substance Flag?Delist Request?
Patented Use:METHOD OF USING VISMODEGIB TO TREAT CANCER IN A MAMMAL
Regulatory Exclusivity Expiration:Jan 30, 2017
Regulatory Exclusivity Use:NEW CHEMICAL ENTITY


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Accenture
Merck
Cipla
Fish and Richardson
US Army
Dow
Johnson and Johnson
McKinsey
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot